Ongoing research continues to expand our understanding of these medications long-term effects and optimal usage
This pathologically cardiac hypertrophy is an independent predictor of adverse cardiovascular outcomes, such as cardiovascular death, heart failure, myocardial infarction, arrhythmia, and stroke 4,5,6
Compounded PT-141 used in functional medicine is the same molecule but not the FDA-approved formulation
Links between short-chain fatty acids and osteoarthritis from pathology to clinic via gut-joint axis
Mn SOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinsons disease and control
Individual participant change in PHQ-9, GAD-7 and EDE-Q scores are shown in Table 1